Su-5402 - A New Ray of Light in the Research for an Anti Cancer Drug

San Diego, CA (PressExposure) February 18, 2011 -- Cancer is a really incurable disease. Loads and loads of money are used and every year to find a cure for this disease but as such not so great results so far. After much research Tivozanib named a drug is discovered which help in curing the patients having and suffering from kidney cancer. Cancer is any form is a deadly disease and this drug is claimed to be the most beneficial and best of the lot which has helped in curing the patients and giving life to the kidneys of persons ailing from kidney cancer. AC22O is a kind of a protein inhibitor which every drug research company should have in order to discover new drugs for curing other kind of diseases. It helps in the discoveries of new drugs in some ways. Also other than helping in the discoveries of new drugs it also helps in curing acute myeloid leukemia. It is a cancerous disease and is extremely which leads to an abnormal growth in the white blood cells. Like the cancer type diseases it was also like incurable. The abnormal growth in the white blood cells restricted the normal growth of the red blood cells which are extremely needed to keep the body in a normal, fit and healthy condition.

With the discovery of the AC220, it became quite possible curing acute myeloid leukemia. This disease affects a person generally at his adult age and the symptoms get on growing worse along with the increase of the age. The work which AC22O actually does is, it stops the abnormal growth of the white bloods so that the growth of the red blood cells does not inhibited and also that the white blood cells can grow at a normal rate on its own.

All this much needed information was gathered from which is an extremely powerful resource of information as well as education in the field of medical research and discovery of new drugs for curing diseases. This site gives much needed information about the remedies of different forms of cancer. FGFR inhibitor and PDGFR inhibitor is an important drug in the field of medical research which have been brought to light by this site.

About supplies Kinase Inhibitors for research use to biotech and pharmaceutical companies involved in drug discovery research, as well as research institutions worldwide.

Press Release Source:

Press Release Submitted On: February 18, 2011 at 4:57 am
This article has been viewed 23160 time(s).